entity

Choline

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Choline: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
21Hypotheses
0Analyses
4Outgoing
1Incoming
14Experiments
0Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

Pedunculopontine Nucleus Cholinergic Neurons in Neurodegeneration

cell · 3946 words

Edinger-Westphal Nucleus Cholinergic Neurons

cell · 2659 words

Striatal Cholinergic Interneurons

cell · 2617 words

Striatal Cholinergic Interneurons in Huntington's Disease

cell · 2541 words

Cholinergic Basal Forebrain Neurons in Alzheimer's Disease

cell · 2495 words

Outgoing (4)

TargetRelationTypeStr
Synapse Formationpromotesprocess0.95
Synapse Formationactivatesprocess0.90
Phosphatide Synthesisactivatespathway0.85
Kennedy Cycleinvolved_inpathway0.85

Incoming (1)

SourceRelationTypeStr
Choline Transporterassociated_withentity0.90

Targeting Hypotheses (21)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa 0.887 - Do β-amyloid plaques and neurofibrillary
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate 0.785 - Do β-amyloid plaques and neurofibrillary
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli 0.769 - Do β-amyloid plaques and neurofibrillary
SASP-Mediated Cholinergic Synapse Disruption 0.763 neurodegeneration Senolytic therapy for age-related neurod
Cholinergic Basal Forebrain-Hippocampal Circuit Protection 0.760 neuroscience Circuit-level neural dynamics in neurode
Endosomal trafficking defects are the common upstream lesion 0.730 neurodegeneration What determines the temporal sequence of
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A 0.669 neurodegeneration What are the mechanisms by which gut mic
Glymphatic-Cholinergic Tau Clearance Cascade 0.666 neuroscience Circuit-level neural dynamics in neurode
Choline Kinase Activity as Membrane Integrity Response Indic 0.663 translational neuroscience Which metabolic biomarkers can distingui
APOE4-microglial complement signaling causes cholinergic-enr 0.630 neurodegeneration What determines the temporal sequence of
Selective Cholinergic Protection via APP Pathway Modulation 0.629 neurodegeneration Clinical Trial Landscaping for Alzheimer
Locus coeruleus degeneration gates whether cholinergic dysfu 0.620 neurodegeneration What determines the temporal sequence of
NAMPT-Centered NAD+ Restoration to Reverse Basal Forebrain C 0.616 neurodegeneration Do β-amyloid plaques and neurofibrillary
Basal forebrain NGF/TrkA trophic failure is an upstream trig 0.610 neurodegeneration What determines the temporal sequence of
TREM2-C1Q Competitive Binding to Prevent Complement-Mediated 0.591 neurodegeneration Do β-amyloid plaques and neurofibrillary
MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN 0.551 neuropharmacology What determines blood-brain barrier pene
Synergistic Timing With Acetylcholinesterase Inhibitors 0.515 - What is the optimal dosage and timing of
Cholinergic Attention Modulation Hypothesis 0.499 methodology Unable to extract research questions - t
Amyloid first impairs cholinergic terminals through alpha7 n 0.450 neurodegeneration What determines the temporal sequence of
Reactive astrocytes and cholinesterase-rich low-acetylcholin 0.440 neurodegeneration What determines the temporal sequence of
SULF-Mediated Protection of Cholinergic Tau Transport Pathwa 0.380 neuroscience Trans-synaptic tau spreading and propaga

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (14)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort clinical Alzheimer's disease 0.950 0.00 Chilean older adults (n=318) w proposed N/A
Electroacupuncture ST37 treatment for DSS-induced colitis in mice validation colitis 0.950 0.00 mice proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Differential GWAS of schizophrenia vs PTSD exploratory schizophrenia, post-traumatic 0.900 0.00 human patients - European ance proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Creation and validation of 3xAD-ChAT-Cre mouse model validation Alzheimer's disease 0.900 0.00 3xAD-ChAT-Cre transgenic mice proposed N/A
HFD-induced cognitive dysfunction and neuroinflammation in mice validation diet-induced cognitive dysfunc 0.900 0.00 adult Swiss male mice proposed N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus exploratory schizophrenia, post-traumatic 0.850 0.00 human brain tissue samples fro proposed N/A
α7nAChR agonist treatment rescues HFD-induced memory deficits validation diet-induced cognitive dysfunc 0.850 0.00 HFD-fed adult Swiss male mice proposed N/A
Microtubule domain analysis in adult axons exploratory 0.800 0.00 adult rodent axons proposed N/A
Tau depletion effects on microtubule domains in adult axons exploratory 0.800 0.00 adult rodent neurons proposed N/A
α7nAChR knockout mice show enhanced HFD sensitivity validation diet-induced cognitive dysfunc 0.800 0.00 Chrna7 knockout mice proposed N/A
Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia. [PMID:40917056] Shuliko LM, Svarovsky DA, Spirina LV, Og Front Biosci (Landmark Ed) 2025 1
CD47-blocking antibody interferes with neutrophil extracellular traps formation [PMID:39951937] Diao Y, Hao M, Xie M, Hu X, Tan R, Wang J Neuroimmunol 2025 1
Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Indu [PMID:40116141] Xie G, Jiang G, Huang L, Sun S, Li X, Wu CNS Neurosci Ther 2025 1
Enhanced anticancer activity of nanoemulsified cardamom extract via modulation o [PMID:41658858] ["Soltani T", "Karimian M", "Vaziri H", Biochemistry and biophysics re 2026 0
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information process [PMID:41453579] Teng T, Yang S, Li J, Wang H, Wu F, He Y Neurobiology of disease 2026 0
Signal-Level Determinants of Cognitive Decline With PPIs versus H2RAs: Transport [PMID:41663888] Saihati HAA, Ahmed BY, Mosaad RM, El-Gar Molecular nutrition & food res 2026 0
Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Ce [PMID:41928597] Gholizadeh F, Hajiaghayi M, Rahbari N, C Eur J Immunol 2026 0
Alpha 7 nicotinic acetylcholine receptor contributes to long-term cognitive reco [PMID:41270982] Nguyen DT, Mendoza K, Hall C, Tan C, Cha Experimental neurology 2026 0
Integrated transcriptomic, proteomic, and metabolomic analyses reveal molecular [PMID:41850064] ["Wang H", "Liu Y", "Jiang K", "Yin J", Poultry science 2026 0
Fragment merging design, synthesis, and biological evaluation of novel methyl Se [PMID:41785527] ["Shaaban S", "Hawas S", "Elmaaty A", "B Bioorganic & medicinal chemist 2026 0
Putative α7-selective ligands interact with α9-containing nicotinic acetylcholin [PMID:41890755] Mobasher M, Hone AJ, Pilzecker M, Bozic Frontiers in immunology 2026 0
Theranekron modulates extracellular matrix and apoptotic signaling pathways in c [PMID:41852375] ["Kuccukturk S", "Duran T", "Vanli S", " Cytotechnology 2026 0
Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers i [PMID:41779471] ["Cruz-Romero S", "Baldi\u00f3n A", "Taw Journal of applied oral scienc 2026 0
Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients W [PMID:41659822] ["Nelson-Taylor S", "Troost J", "Giannin Kidney medicine 2026 0
Encapsulation of hydroxyurea in exosomes derived from adipose mesenchymal stem c [PMID:41702234] ["Taheri Kangarshahi Z", "Ganji S", "Ash Translational oncology 2026 0
Short-term exposure to a high-fat diet leads to neuroinflammation and impairs me [PMID:41565126] Costa SO, Silva IM, Chaves WF, Esteves A The Journal of nutritional bio 2026 0
Acetylcholine enhances HIF-1α signaling in pancreatic cancer cells under hypoxia [PMID:41608625] Cho Y, Kim HG, Kang JH, Oh ET, Park HJ International journal of biolo 2026 0
NSUN2 promoted tumor growth and metastatic via m [PMID:41794778] ["Li R", "Jin D", "Shao S", "Guo J"] Cell death & disease 2026 0
Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Role [PMID:40867559] ["Jadhav D", "Knapinska A", "Wang H", "F Biomolecules 2025 0
Central-peripheral neuroimmune dynamics in psychological stress and depression: [PMID:40610703] Feng X, Jia M, Cai M, Zhu T, Hashimoto K Molecular psychiatry 2025 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Choline in their description or question text

Endosomal trafficking defects are the common upstream lesion linking APP process

Score: 0.730 · neurodegeneration · 2026-04-25

AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting

Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Com

Score: 0.669 · neurodegeneration · 2026-04-02

## Mechanistic Overview Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication start

Glymphatic-Cholinergic Tau Clearance Cascade

Score: 0.666 · neuroscience · 2026-04-07

## Mechanistic Overview Glymphatic-Cholinergic Tau Clearance Cascade starts from the claim that modulating MAPT within t

Choline Kinase Activity as Membrane Integrity Response Indicator

Score: 0.663 · translational neuroscience · 2026-04-16

**Molecular Mechanism and Rationale** Choline kinase alpha (CHKA) represents a critical regulatory enzyme in phospholip

APOE4-microglial complement signaling causes cholinergic-enriched synaptic vulne

Score: 0.630 · neurodegeneration · 2026-04-25

APOE4 may bias microglia toward complement-mediated pruning that disproportionately strips vulnerable long-range choline

Selective Cholinergic Protection via APP Pathway Modulation

Score: 0.629 · neurodegeneration · 2026-04-04

## Mechanistic Overview Selective Cholinergic Protection via APP Pathway Modulation starts from the claim that modulatin

Locus coeruleus degeneration gates whether cholinergic dysfunction or amyloid/ta

Score: 0.620 · neurodegeneration · 2026-04-25

Early noradrenergic loss may shift inflammatory tone, amyloid clearance, and cholinergic resilience, thereby modulating

NAMPT-Centered NAD+ Restoration to Reverse Basal Forebrain Cholinergic Neuron Me

Score: 0.616 · neurodegeneration · 2026-04-16

## **Molecular Mechanism and Rationale** The nicotinamide adenine dinucleotide (NAD+) biosynthetic pathway represents a

Basal forebrain NGF/TrkA trophic failure is an upstream trigger that makes choli

Score: 0.610 · neurodegeneration · 2026-04-25

Loss of retrograde NGF-TrkA support could destabilize basal-forebrain cholinergic neurons early, lowering cortical acety

TREM2-C1Q Competitive Binding to Prevent Complement-Mediated Cholinergic Synapse

Score: 0.591 · neurodegeneration · 2026-04-16

**Molecular Mechanism and Rationale** The TREM2-C1Q competitive binding hypothesis centers on the intricate molecular i

MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Reso

Score: 0.551 · neuropharmacology · 2026-04-13

## Mechanistic Overview MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Resolving Prodrugs s

Synergistic Timing With Acetylcholinesterase Inhibitors

Score: 0.515 · unknown disease · 2026-04-26

Scheduled 3mg melatonin 30 minutes after donepezil administration optimizes MT1/AChE-inhibitor cross-talk for amyloid an

Cholinergic Attention Modulation Hypothesis

Score: 0.499 · methodology · 2026-04-12

## Mechanistic Overview Cholinergic Attention Modulation Hypothesis starts from the claim that modulating CHRNA7 within

Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-de

Score: 0.450 · neurodegeneration · 2026-04-25

Soluble amyloid oligomers may injure cholinergic terminals via CHRNA7-linked calcium dysregulation, making cholinergic d

Reactive astrocytes and cholinesterase-rich low-acetylcholine niches amplify tau

Score: 0.440 · neurodegeneration · 2026-04-25

Reactive astrocytes may degrade acetylcholine and destabilize cortical network states, secondarily creating conditions p